Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women

Gynecological Endocrinology

Volumn 27, Issue 12, 2011, Pages 1023-1027

  Łaczmański, Łukasz ^a   Milewicz, Andrzej ^a   Dunajska, Katarzyna ^b   Jedrzejczuk, Diana ^a   Pawlak, Maurycy ^a   Lwow, Felicja ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

Author keywords

cardiovascular risk; CNR1 polymorphism; obesity; postmenopausal women

Indexed keywords

ANDROGEN; ENDOCANNABINOID; ESTROGEN; GLUCOSE; INSULIN; LIPID;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; BODY FAT DISTRIBUTION; BODY MASS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RECEPTOR GENE; WAIST CIRCUMFERENCE;

BODY WEIGHTS AND MEASURES; CARDIOVASCULAR DISEASES; COHORT STUDIES; ENDOCANNABINOIDS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RECEPTOR, CANNABINOID, CB1; RISK FACTORS;

EID: 80955158245     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.569796     Document Type: Article

References (8)

1. Russo P, Strazzullo P, Cappuccio FP, Tregouet DA, Lauria F, Loguercio M, Barba G, Versiero M, Siani A. Genetic variations at the endocannabinoid Type 1 receptor gene (CNR1) are associated with obesity phenotypes in men. J Clin Endocrinol Metab 2007;92:2382-2386.
2. Carr TP, Jesch ED, Brown AW. Endocannabinoids, metabolic regulation, and the role of diet. Nutr Res 2008;28:641-650.
3. Komorowski J, StepieńH. The role of the endocannabinoid system in the regulation of endocrine function and in the control of energy balance in humans. Postepy Hig Med Dosw 2007;61:99-105.
4. Baye TM, Zhang Y, Smith E, Hillard CJ, Gunnell J, Myklebust J, James R, Kissebah AH, Olivier M, Wilke RA. Genetic variation in cannabinoid receptor 1 (CNR1) is associated with dngements in lipid homeostasis, independent of body mass index. Pharmacogenomics 2008;9:1647-1656.
5. Bordicchiaa M, Battistonia I, Mancinellia L, Gianninia E, Refia G, Minardib E, Muzzonigrob G, Mazzucchellic R, Montironic R, Piscitellid F, et al. Cannabinoid CB1 receptor expression in relation to viscl adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans. Metabolism 2010;59:734-741.
6. Benzinou M, Che'vre JC, Ward KJ, Lecoeur C, Dina C, Lobbens S, Durand E, Delplanque J, Horber FF, Heude B, et al. Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. Hum Mol Genet 2008;17:1916-1921.
7. Greenfield JR, Samaras K, Chisholm DJ. Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2002;87:1036-1040.
8. Wajchenberg BL. Subcutaneous and viscl adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:637-738.